PuSH - Publication Server of Helmholtz Zentrum München

86 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Graae, A.S.* et al.: ADAMTS9 regulates skeletal muscle insulin sensitivity through extracellular matrix alterations. Diabetes 68, 502-514 (2019)
2.
Jaghutriz, B.A. et al.: Gene x gene interactions highlight the role of incretin resistance for insulin secretion. Front. Endocrin. 10:72 (2019)
3.
Ji, Y.* et al.: Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension. Diabetes 68, 207-219 (2019)
4.
Kempe-Teufel, D. et al.: A polygenic risk score of lipolysis-increasing alleles determines visceral fat mass and proinsulin conversion. J. Clin. Endocrinol. Metab. 104, 1090-1098 (2019)
5.
Keuper, M. et al.: Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin. Mol. Metab. 20, 28-37 (2019)
6.
Keuper, M. ; Häring, H.-U. & Staiger, H.: Circulating FGF21 levels in human health and metabolic disease. Exp. Clin. Endocrinol. Diabet., accepted (2019)
7.
Wagner, R. & Staiger, H.: Genetic background of type 2 diabetes. Diabetologe 15, 267-277 (2019)
8.
Wang, X. et al.: Point mutations in the PDX1 transactivation domain impair human β-cell development and function. Mol. Metab., accepted (2019)
9.
Gerlini, R. et al.: Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity. Mol. Metab. 18, 42-50 (2018)
10.
Gerst, F. et al.: The expression of aldolase B in islets is negatively associated with insulin secretion in humans. J. Clin. Endocrinol. Metab. 103, 4373-4383 (2018)
11.
Gottmann, P.* et al.: A computational biology approach of a genome-wide screen connected miRNAs to obesity and type 2 diabetes. Mol. Metab. 11, 145-159 (2018)
12.
Kantartzis, K. et al.: Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes. Metab. 20, 1793-1797 (2018)
13.
Lutz, S.Z. et al.: Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes. Endocr. Relat. Cancer 25, L19-L22 (2018)
14.
Lutz, S.Z. et al.: Single nucleotide polymorphisms in the G-protein coupled receptor kinase 5 (GRK5) gene are associated with plasma LDL-cholesterol levels in humans. Sci. Rep. 8:7745 (2018)
15.
Nuñez-Durán, E.* et al.: Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. Hepat. Commun. 2, 69-83 (2018)
16.
Ordelheide, A.-M. ; Hrabě de Angelis, M. ; Häring, H.-U. & Staiger, H.: Pharmacogenetics of oral antidiabetic therapy. Pharmacogenomics 19, 577-587 (2018)
17.
Rozman, J. et al.: Identification of genetic elements in metabolism by high-throughput mouse phenotyping.   Nat. Commun. 9:288 (2018)
18.
Stirm, L. et al.: Maternal whole blood cell miRNA-340 is elevated in gestational diabetes and inversely regulated by glucose and insulin. Sci. Rep. 8:1366 (2018)
19.
Stirm, L. et al.: BMI-independent effects of gestational diabetes on human placenta. J. Clin. Endocrinol. Metab. 103, 3299-3309 (2018)
20.
Suwandhi, L. et al.: Chronic d-serine supplementation impairs insulin secretion. Mol. Metab., accepted (2018)